nodes	percent_of_prediction	percent_of_DWPC	metapath
Mafenide—Excoriation—Tretinoin—peripheral nervous system neoplasm	0.0447	0.0447	CcSEcCtD
Mafenide—Excoriation—Isotretinoin—peripheral nervous system neoplasm	0.0447	0.0447	CcSEcCtD
Mafenide—Tachypnoea—Tretinoin—peripheral nervous system neoplasm	0.0395	0.0395	CcSEcCtD
Mafenide—Tachypnoea—Isotretinoin—peripheral nervous system neoplasm	0.0395	0.0395	CcSEcCtD
Mafenide—Disseminated intravascular coagulation—Tretinoin—peripheral nervous system neoplasm	0.0378	0.0378	CcSEcCtD
Mafenide—Disseminated intravascular coagulation—Isotretinoin—peripheral nervous system neoplasm	0.0378	0.0378	CcSEcCtD
Mafenide—Excoriation—Alitretinoin—peripheral nervous system neoplasm	0.0339	0.0339	CcSEcCtD
Mafenide—Tachypnoea—Alitretinoin—peripheral nervous system neoplasm	0.03	0.03	CcSEcCtD
Mafenide—Disseminated intravascular coagulation—Alitretinoin—peripheral nervous system neoplasm	0.0287	0.0287	CcSEcCtD
Mafenide—Acidosis—Isotretinoin—peripheral nervous system neoplasm	0.0244	0.0244	CcSEcCtD
Mafenide—Acidosis—Tretinoin—peripheral nervous system neoplasm	0.0244	0.0244	CcSEcCtD
Mafenide—Metabolic acidosis—Etoposide—peripheral nervous system neoplasm	0.0202	0.0202	CcSEcCtD
Mafenide—Bone marrow depression—Melphalan—peripheral nervous system neoplasm	0.0197	0.0197	CcSEcCtD
Mafenide—Blister—Isotretinoin—peripheral nervous system neoplasm	0.0187	0.0187	CcSEcCtD
Mafenide—Blister—Tretinoin—peripheral nervous system neoplasm	0.0187	0.0187	CcSEcCtD
Mafenide—Acidosis—Alitretinoin—peripheral nervous system neoplasm	0.0185	0.0185	CcSEcCtD
Mafenide—Bone marrow depression—Vincristine—peripheral nervous system neoplasm	0.0146	0.0146	CcSEcCtD
Mafenide—Blister—Alitretinoin—peripheral nervous system neoplasm	0.0142	0.0142	CcSEcCtD
Mafenide—Swelling—Tretinoin—peripheral nervous system neoplasm	0.0111	0.0111	CcSEcCtD
Mafenide—Swelling—Isotretinoin—peripheral nervous system neoplasm	0.0111	0.0111	CcSEcCtD
Mafenide—Haemolytic anaemia—Melphalan—peripheral nervous system neoplasm	0.0107	0.0107	CcSEcCtD
Mafenide—Dermatitis bullous—Topotecan—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Mafenide—Dermatitis bullous—Tretinoin—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Mafenide—Dermatitis bullous—Isotretinoin—peripheral nervous system neoplasm	0.0103	0.0103	CcSEcCtD
Mafenide—Face oedema—Isotretinoin—peripheral nervous system neoplasm	0.00947	0.00947	CcSEcCtD
Mafenide—Face oedema—Tretinoin—peripheral nervous system neoplasm	0.00947	0.00947	CcSEcCtD
Mafenide—Swelling—Alitretinoin—peripheral nervous system neoplasm	0.00842	0.00842	CcSEcCtD
Mafenide—Pancytopenia—Topotecan—peripheral nervous system neoplasm	0.00811	0.00811	CcSEcCtD
Mafenide—Pancytopenia—Melphalan—peripheral nervous system neoplasm	0.00794	0.00794	CcSEcCtD
Mafenide—Dermatitis bullous—Alitretinoin—peripheral nervous system neoplasm	0.00777	0.00777	CcSEcCtD
Mafenide—Face oedema—Alitretinoin—peripheral nervous system neoplasm	0.00717	0.00717	CcSEcCtD
Mafenide—Haemolytic anaemia—Cisplatin—peripheral nervous system neoplasm	0.00701	0.00701	CcSEcCtD
Mafenide—Haemoglobin—Topotecan—peripheral nervous system neoplasm	0.00687	0.00687	CcSEcCtD
Mafenide—Haemorrhage—Topotecan—peripheral nervous system neoplasm	0.00684	0.00684	CcSEcCtD
Mafenide—Haemoglobin—Tretinoin—peripheral nervous system neoplasm	0.00682	0.00682	CcSEcCtD
Mafenide—Haemoglobin—Isotretinoin—peripheral nervous system neoplasm	0.00682	0.00682	CcSEcCtD
Mafenide—Haemorrhage—Isotretinoin—peripheral nervous system neoplasm	0.00678	0.00678	CcSEcCtD
Mafenide—Haemorrhage—Tretinoin—peripheral nervous system neoplasm	0.00678	0.00678	CcSEcCtD
Mafenide—Haemoglobin—Melphalan—peripheral nervous system neoplasm	0.00673	0.00673	CcSEcCtD
Mafenide—Haemorrhage—Melphalan—peripheral nervous system neoplasm	0.00669	0.00669	CcSEcCtD
Mafenide—Bone marrow depression—Epirubicin—peripheral nervous system neoplasm	0.00663	0.00663	CcSEcCtD
Mafenide—Pancytopenia—Dactinomycin—peripheral nervous system neoplasm	0.00658	0.00658	CcSEcCtD
Mafenide—Swelling—Etoposide—peripheral nervous system neoplasm	0.00657	0.00657	CcSEcCtD
Mafenide—Hyperventilation—Epirubicin—peripheral nervous system neoplasm	0.00651	0.00651	CcSEcCtD
Mafenide—Burning sensation—Epirubicin—peripheral nervous system neoplasm	0.00645	0.00645	CcSEcCtD
Mafenide—Blister—Epirubicin—peripheral nervous system neoplasm	0.00621	0.00621	CcSEcCtD
Mafenide—Bone marrow depression—Doxorubicin—peripheral nervous system neoplasm	0.00614	0.00614	CcSEcCtD
Mafenide—Face oedema—Cisplatin—peripheral nervous system neoplasm	0.00611	0.00611	CcSEcCtD
Mafenide—Hyperventilation—Doxorubicin—peripheral nervous system neoplasm	0.00602	0.00602	CcSEcCtD
Mafenide—Burning sensation—Doxorubicin—peripheral nervous system neoplasm	0.00597	0.00597	CcSEcCtD
Mafenide—Erythema—Tretinoin—peripheral nervous system neoplasm	0.0059	0.0059	CcSEcCtD
Mafenide—Erythema—Isotretinoin—peripheral nervous system neoplasm	0.0059	0.0059	CcSEcCtD
Mafenide—Pancytopenia—Vincristine—peripheral nervous system neoplasm	0.00588	0.00588	CcSEcCtD
Mafenide—Blister—Doxorubicin—peripheral nervous system neoplasm	0.00575	0.00575	CcSEcCtD
Mafenide—Pancytopenia—Cisplatin—peripheral nervous system neoplasm	0.0052	0.0052	CcSEcCtD
Mafenide—Haemoglobin—Alitretinoin—peripheral nervous system neoplasm	0.00517	0.00517	CcSEcCtD
Mafenide—Haemorrhage—Alitretinoin—peripheral nervous system neoplasm	0.00514	0.00514	CcSEcCtD
Mafenide—Erythema—Dactinomycin—peripheral nervous system neoplasm	0.00483	0.00483	CcSEcCtD
Mafenide—Pancytopenia—Etoposide—peripheral nervous system neoplasm	0.00476	0.00476	CcSEcCtD
Mafenide—Erythema—Alitretinoin—peripheral nervous system neoplasm	0.00447	0.00447	CcSEcCtD
Mafenide—Pain—Topotecan—peripheral nervous system neoplasm	0.00415	0.00415	CcSEcCtD
Mafenide—Pain—Tretinoin—peripheral nervous system neoplasm	0.00412	0.00412	CcSEcCtD
Mafenide—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00412	0.00412	CcSEcCtD
Mafenide—Pain—Melphalan—peripheral nervous system neoplasm	0.00407	0.00407	CcSEcCtD
Mafenide—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00386	0.00386	CcSEcCtD
Mafenide—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00383	0.00383	CcSEcCtD
Mafenide—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00383	0.00383	CcSEcCtD
Mafenide—Erythema—Cisplatin—peripheral nervous system neoplasm	0.00381	0.00381	CcSEcCtD
Mafenide—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00378	0.00378	CcSEcCtD
Mafenide—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00344	0.00344	CcSEcCtD
Mafenide—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00341	0.00341	CcSEcCtD
Mafenide—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00341	0.00341	CcSEcCtD
Mafenide—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.0034	0.0034	CcSEcCtD
Mafenide—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00337	0.00337	CcSEcCtD
Mafenide—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00337	0.00337	CcSEcCtD
Mafenide—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00332	0.00332	CcSEcCtD
Mafenide—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.0033	0.0033	CcSEcCtD
Mafenide—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.0033	0.0033	CcSEcCtD
Mafenide—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00325	0.00325	CcSEcCtD
Mafenide—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.00315	0.00315	CcSEcCtD
Mafenide—Face oedema—Epirubicin—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Mafenide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00312	0.00312	CcSEcCtD
Mafenide—Rash—Topotecan—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Mafenide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00306	0.00306	CcSEcCtD
Mafenide—Rash—Tretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Mafenide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Mafenide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Mafenide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Mafenide—Pain—Vincristine—peripheral nervous system neoplasm	0.00301	0.00301	CcSEcCtD
Mafenide—Rash—Melphalan—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Mafenide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.003	0.003	CcSEcCtD
Mafenide—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.0029	0.0029	CcSEcCtD
Mafenide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.0029	0.0029	CcSEcCtD
Mafenide—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.00278	0.00278	CcSEcCtD
Mafenide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00269	0.00269	CcSEcCtD
Mafenide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00267	0.00267	CcSEcCtD
Mafenide—Pain—Cisplatin—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Mafenide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00258	0.00258	CcSEcCtD
Mafenide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00257	0.00257	CcSEcCtD
Mafenide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Mafenide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00248	0.00248	CcSEcCtD
Mafenide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Mafenide—Pain—Etoposide—peripheral nervous system neoplasm	0.00244	0.00244	CcSEcCtD
Mafenide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00241	0.00241	CcSEcCtD
Mafenide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Mafenide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.0023	0.0023	CcSEcCtD
Mafenide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Mafenide—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Mafenide—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.00225	0.00225	CcSEcCtD
Mafenide—Rash—Vincristine—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Mafenide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Mafenide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00213	0.00213	CcSEcCtD
Mafenide—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Mafenide—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.00208	0.00208	CcSEcCtD
Mafenide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00202	0.00202	CcSEcCtD
Mafenide—Rash—Cisplatin—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Mafenide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Mafenide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.00196	0.00196	CcSEcCtD
Mafenide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00195	0.00195	CcSEcCtD
Mafenide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.00181	0.00181	CcSEcCtD
Mafenide—Rash—Etoposide—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Mafenide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.0018	0.0018	CcSEcCtD
Mafenide—Pain—Epirubicin—peripheral nervous system neoplasm	0.00137	0.00137	CcSEcCtD
Mafenide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00127	CcSEcCtD
Mafenide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00126	0.00126	CcSEcCtD
Mafenide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00117	0.00117	CcSEcCtD
Mafenide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00113	0.00113	CcSEcCtD
Mafenide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Mafenide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00105	0.00105	CcSEcCtD
Mafenide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Mafenide—Rash—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Mafenide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00101	0.00101	CcSEcCtD
Mafenide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000932	0.000932	CcSEcCtD
Mafenide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000931	0.000931	CcSEcCtD
